Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2h)-yl)-n,4-dimethylbenzamide
AssigneePfizer Inc.
InventorsDaniel Dukesherer, Michael Mao, Richard Vonder Embse, Gopi Yalamanchili, Rajappa Vaidyanathan, Brian Chekal, George Klemm, Ronald VanderRoset, Randy Geurink
Life of this patent
Estimating the term…
Abstract
This invention is directed generally to processes for the preparation of compounds of Formula I: wherein R2, R3, R4, R5, X1, X2, X3, X4, X5, X6 are as defined in the specification.
Claims130
The process for the preparation of a compound of Formula I:
- comprising the steps of:
- a) contacting a compound of Formula V:
- with a halogenating reagent in the presence of at least one solvent to produce a compound of Formula IV:
- b) contacting a compound of Formula IV with a substituted benzylhalide in the presence of at least one solvent and a base to produce a compound of Formula III:
- c) contacting a compound of Formula III with a base in the presence of at least one solvent to produce a compound of Formula II:
- d) contacting a compound of Formula II with a activating reagent in the presence of at least one solvent and then contacting the resulting mixture with an amine to produce a compound of Formula I;
- wherein
- X1, X2, X3, X4, X5 and X6 are independently H, halo, or a C1-C6 alkyl;
- R1 is a C1-C6 alkyl or aryl;
- R2 is H, halo, or a C1-C6 alkyl;
- R3 is halo, or a C1-C6 alkyl;
- and
- R4 is H or a C1-C6 alkyl;
- R5 is H, a C1-C6 alkyl or aryl;
- or
- R4, R5, and the nitrogen to which they are attached form a morpholinyl, thiomorpholinyl, piperidinyl, pyrrolidinyl, or piperazinyl ring which is optionally substituted with 1 or 2 groups that are independently C1-C4 alkyl, C1-C4 alkoxy, hydroxy, hydroxy C1-C4 alkyl, C1-C4 dihydroxyalkyl, or halogen.
A process for the preparation of a compound of Formula I:
- comprising the steps:
- a) contacting a compound of formula V:
- with a halogenating reagent in the presence of at least one solvent to produce a compound of Formula IV:
- b) contacting a compound of Formula IV with an hydrolase in the presence of a buffer solution to produce a compound of Formula X:
- c) contacting a compound of Formula X with a activating reagent in the presence of at least one solvent and then contacting the resulting mixture with an amine to produce a compound of Formula IX:
- d) contacting a compound of Formula IX with a substituted benzylhalide in the presence of a base and at least one solvent to produce a compound of Formula I;
- wherein
- X1, X2, X3, X4, X5 and X6 are independently H, halo, or a C1-C6 alkyl;
- R1 is a C1-C6 alkyl or aryl;
- R2 is H, halo, or a C1-C6 alkyl;
- R3 is halo, or a C1-C6 alkyl;
- and
- R4 is H or a C1-C6 alkyl;
- R5 is H, a C1-C6 alkyl or aryl;
- or
- R4, R5, and the nitrogen to which they are attached form a morpholinyl, thiomorpholinyl, piperidinyl, pyrrolidinyl, or piperazinyl ring which is optionally substituted with 1 or 2 groups that are independently C1-C4 alkyl, C1-C4 alkoxy, hydroxy, hydroxy C1-C4 alkyl, C1-C4 dihydroxyalkyl, or halogen.
A process for the preparation of a compound of Formula I having the following structure:
- comprising the steps:
- a) contacting a compound of formula V having the following structure:
- with 1,3-dibromo-5,5-dimethylhydantoin in the presence of acetonitrile to produce a compound of Formula IV having the following structure:
- b) contacting a compound of Formula IV with Bacillus sp. protease in the presence of a potassium phosphate buffer solution to produce a compound of Formula X having the following structure:
- c) contacting a compound of Formula X with 1,1′-carbonyldiimidazole in the presence of dimethylformamide and then the resulting mixture is contacted with NH2CH3 in tetrahydrofuran to produce a compound of Formula IX having the following structure:
- d) contacting a compound of Formula IX with a compound having the following structure:
- in the presence of potassium carbonate and N-methylpyrrolidinone.
The compound methyl 3-(3-bromo-4-hydroxy-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoate or a pharmaceutically acceptable salt thereof.
The compound (+)-methyl 3-(3-bromo-4-hydroxy-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoate or a pharmaceutically acceptable salt thereof.
The compound 3-(3-bromo-4-hydroxy-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide or a pharmaceutically acceptable salt thereof.
The compound 3-(3-bromo-4-hydroxy-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoic acid or a pharmaceutically acceptable salt thereof.
The compound (−)-3-(3-bromo-4-hydroxy-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoic acid or a pharmaceutically acceptable salt thereof.
The compound (−)-1-(5-(1H-imidazole-1-carbonyl)-2-methylphenyl)-3-bromo-4-hydroxy-6-methylpyridin-2(1H)-one or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.